SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 18th, 2024 • Imunon, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of [●], 2024, between Imunon, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK IMUNON, INC.Imunon, Inc. • January 18th, 2024 • Pharmaceutical preparations
THIS PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from IMUNON, INC., a Delaware corporation (the “Company”), up to ______ shares of Common Stock, par value $0.01 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Imunon, Inc. Attention: Dr. Corinne Le GoffImunon, Inc. • January 18th, 2024 • Pharmaceutical preparations • New York
